Clinical Treatment Guidelines for Mitral Valve Endocarditis
Surgery of the native mitral valve is indicated in patients with acute infective endocarditis who present with valve regurgitation resulting in heart failure, hemodynamic compromise, or when caused by highly resistant organisms. 1
Antibiotic Therapy
For Native Mitral Valve Endocarditis
Empiric Therapy (Before Culture Results)
- First-line: Vancomycin (30 mg/kg/day IV in 2 divided doses) 1
- Duration: Continue until culture results are available
Targeted Therapy Based on Organism
Penicillin-susceptible streptococci:
Staphylococcal endocarditis:
Culture-negative endocarditis:
- Ampicillin-sulbactam (12g/24h IV in 4 divided doses) plus
- Gentamicin (3 mg/kg/24h IV/IM in 3 divided doses)
- Duration: 4-6 weeks 1
Fungal endocarditis:
Surgical Management
Indications for Urgent/Emergency Surgery
Heart failure (Class I recommendation):
Uncontrolled infection (Class I recommendation):
Prevention of embolism (Class I recommendation):
Surgical Principles
For native valve endocarditis:
For prosthetic valve endocarditis:
Special Considerations
Anticoagulation Management
- Patients with prosthetic valves on warfarin who develop endocarditis should:
Monitoring During Treatment
- Repeat echocardiography is warranted when:
- Patient develops worsening heart failure symptoms
- New cardiac murmurs appear
- New atrioventricular block or arrhythmia develops 3
Prognostic Factors
- Moderate to severe heart failure is the most important predictor of in-hospital, 6-month, and 1-year mortality 3
- Patients with vegetation diameter >10 mm have significantly higher incidence of embolization, with risk appearing higher in mitral valve endocarditis than aortic valve endocarditis 1
Common Pitfalls and Caveats
Delayed surgical intervention: Staphylococcal infections are particularly destructive and nearly always require urgent surgery before infection control can be achieved 1
Inadequate duration of therapy: Antibiotic treatment should continue for at least 4-6 weeks to prevent failure or relapse 4
Failure to recognize complications: Heart failure occurs in 42-60% of native valve endocarditis cases and is the most frequent complication 3
Inappropriate antibiotic dosing: Cell-wall-active antibiotics require concentrations above MIC for as long as possible between administrations 4
Overlooking the potential for valve repair: Mitral valve repair is the best therapeutic option when technically possible, but requires early intervention, especially with virulent organisms 5